Michael Burry's top holdings (October 2025) include Estee Lauder Cos., Inc. (EL), a global leader in prestige beauty products with a diverse portfolio of skincare, makeup, fragrance, and hair care brands.

Michael Burry is the founder and portfolio manager of Scion Asset Management, a hedge fund based in Cupertino, California. His investment focus is known for a value-oriented, fundamental approach, often seeking out overlooked or mispriced opportunities in various markets.

Estee Lauder Cos., Inc. (EL)

Estee Lauder Cos., Inc. is a prominent global manufacturer and marketer of quality skincare, makeup, fragrance, and hair care products. Their extensive brand portfolio reaches consumers worldwide through department stores, specialty retail, and online channels. Estee Lauder Cos., Inc. holds a market capitalization of $31.19 billion, with Michael Burry's position in the company currently valued at $13.22 million. Analysts have set a price target of $85.0 for the stock, while a discounted cash flow analysis indicates a value of $35.52 per share.

Here's an overview of Michael Burry's trades in Estee Lauder Cos., Inc.:

Lululemon Athletica inc. (LULU)

Lululemon Athletica inc. is a global athletic apparel and accessories company, primarily known for its yoga-inspired clothing. The company designs, manufactures, and sells a range of performance apparel and accessories for yoga, running, training, and other activities. The company's market cap stands at $20.0 billion, while the current value of Michael Burry's holding in Lululemon Athletica Inc. is $8.9 million. Its discounted cash flow value is $573.79, and analysts forecast a price target of $190.0.

Here's an overview of Michael Burry's trades in Lululemon Athletica inc.:

Regeneron Pharmaceuticals, Inc. (REGN)

Regeneron Pharmaceuticals, Inc. is a leading biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. The company's innovative approach focuses on antibody technologies to address unmet medical needs. Regeneron Pharmaceuticals, Inc. has a market capitalization of $58.74 billion, with Michael Burry's position currently valued at $8.43 million. Analysts have set a price target of $662.29 for the company, and its discounted cash flow analysis suggests a value of $2.02K per share.

Here's an overview of Michael Burry's trades in Regeneron Pharmaceuticals, Inc.:

Bruker Corp (BRKR)

Bruker Corp is a manufacturer of scientific instruments and analytical and diagnostic solutions. The company's products are used in life science research, molecular diagnostics, and industrial and applied analysis globally. This holding in Michael Burry's portfolio is currently worth $8.12 million. Bruker Corp's market capitalization is $4.71 billion. Its discounted cash flow value is $71.12, with analysts targeting a price of $47.67.

Here's an overview of Michael Burry's trades in Bruker Corp:

MercadoLibre Inc (MELI)

MercadoLibre Inc operates as an e-commerce platform and digital payments provider in Latin America. The company offers a suite of services including online marketplaces, payments, advertising, and logistics solutions. MercadoLibre Inc has a market capitalization of $125.14 billion. The current value of Michael Burry's position in this company is $7.01 million. Analysts project a price target of $2.87K for the stock, while its discounted cash flow is estimated at $1.46K.

Here's an overview of Michael Burry's trades in MercadoLibre Inc: